DRUG · Unmapped registry intervention
GW572016 (lapatinib)
Find medicine records ·
Find other trials using this name
Clinical trial
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
NCT00073008
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancer, Non-Small Cellunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
HoustonTexas, United States1PhiladelphiaPennsylvania, United States1TorontoOntario, Canada1NashvilleTennessee, United States1ClevelandOhio, United States1PortlandOregon, United States1DurhamNorth Carolina, United States1Washington D.C.District of Columbia, United States1Chapel HillNorth Carolina, United States1La JollaCalifornia, United States1OttawaOntario, Canada1Long BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00073008 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.